Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Paul Manning
AddedMar 31, 2024
UpdatedJun 28, 2026
Paul Manning

Paul Manning

Board Member, PBM Capital Group

CrunchbaseLinkedIn

Paul Manning's Career

PBM Capital Group
PBM Capital Group

Charlottesville, VA, US

Board Member· Board
Verrica Pharmaceuticals
Verrica Pharmaceuticals

West Chester, PA, US

Board Member· Board
Candel Therapeutics
Candel Therapeutics

Needham, MA, US

Board Member· Board
Xalud Therapeutics
Xalud Therapeutics

New York City, NY, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Paul Manning's Career

PBM Capital Group
PBM Capital Group
Investment FirmInvestment Firm252010Charlottesville, VA, US
Board Member· Board

Similar to PBM Capital Group

PFM Health SciencesPFM Health SciencesSan Francisco, CA, USest. 2004PFM Health SciencesSan Francisco, CA, US · est. 2004

PFM Health Sciences: A San Francisco-based firm specializing in healthcare investment management.

Investment Firm75
Patient Square CapitalPatient Square CapitalMenlo Park, CA, USest. 2020Patient Square CapitalMenlo Park, CA, US · est. 2020

Patient Square Capital: A healthcare investment firm fostering growth in health-focused organizations.

Investment Firm66
PBJ CapitalPBJ CapitalLincoln, MA, USPBJ CapitalLincoln, MA, US

PBJ Capital LLC: A technology investment firm specializing in early-stage financing services.

Investment Firm6
Pappas CapitalPappas CapitalDurham, NC, USest. 1994Pappas CapitalDurham, NC, US · est. 1994

Pappas Capital: A dedicated life science investor, building innovative companies for 26 years.

Investment Firm31
Verrica Pharmaceuticals
Verrica Pharmaceuticals

West Chester, PA, US

Board Member· Board
Candel Therapeutics
Candel Therapeutics

Needham, MA, US

Board Member· Board
Xalud Therapeutics
Xalud Therapeutics

New York City, NY, US

Board Member· Board

Paul Manning's Co-Investors

Roger JeffsRoger JeffsCo-invested · Post Ipo EquityHongkouHongkouCo-invested · Series BHongkouHongkouCo-invested · Series BAMDG 1AMDG 1Co-invested · Post Ipo EquityJenny RookeJenny RookeCo-invested · Series UnknownLowry CaudillLowry CaudillCo-invested · Series AWilliam N. StarlingWilliam N. StarlingCo-invested · Series AAlfred ChildersAlfred ChildersCo-invested · Series A

Paul Manning's Similar Executives & Operators

Lee Sirg-OoLee Sirg-OoCEO · DunamuChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · DunamuIn-hyuk ChoiIn-hyuk ChoiCEO · Naver FinancialDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailPark Hyeon-JooPark Hyeon-JooFounder · Mirae AssetAshish DaveAshish DaveCEO · Mirae Asset

People Similar to Paul Manning

Paul-Peter TakPaul-Peter TakCEO · Candel TherapeuticsEstuardo Aguilar-CordovaEstuardo Aguilar-CordovaBoard Member · Candel TherapeuticsGeeta VemuriGeeta VemuriCo-Founder · Agent CapitalErkki RuoslahtiErkki RuoslahtiCo-Founder · Lisata TherapeuticsJoe PapaJoe PapaBoard Member · Candel TherapeuticsWerner CautreelsWerner CautreelsBoard Member · Thuja Capital